ArticleDiabetes, obesity & metabolism2026
Cost-effectiveness analysis of Dexcom ONE+ real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with type 2 diabetes in Aotearoa New Zealand.
Ryan G Paul et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.